Search

everythinglearnresearchcommunity

for

Search:↓

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Recognize Polish academic titles as proof of language proficiency for foreign-trained doctors.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Anti-CD19 therapy may help treat SLE and NMOSD.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Aortic aneurysm treatment has shifted to less invasive methods, improving safety and outcomes.

Trans-esophageal echocardiography is crucial for accurately diagnosing heart issues in lupus patients.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Correct diagnosis is crucial for treating overlapping conditions like NMOSD and SLE effectively.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Ruxolitinib treatment may cause eyelash growth.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

New treatments and understanding of skin lupus are emerging in 2024.

Upadacitinib may effectively treat alopecia areata without side effects.

Topical treatments helped a child with Down syndrome and severe hair loss regrow most of his hair.

Cancer treatments often cause skin, nail, and hair problems.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.